Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May;63(5):1311-1319.
doi: 10.1007/s10620-018-5009-4. Epub 2018 Mar 9.

Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer

Prashanthi N Thota  1   2 , Zubin Arora  3 , John A Dumot  4 , Gary Falk  5 , Tanmayee Benjamin  3 , John Goldblum  6 , Sunguk Jang  3 , Rocio Lopez  7 , John J Vargo  3
Affiliations

Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer

Prashanthi N Thota et al. Dig Dis Sci. 2018 May.

Abstract

Background and aims: Endoscopic ablation therapy has become the mainstay of treatment of Barrett's associated dysplasia and intramucosal cancer (IMC). The widely available techniques for ablation are radiofrequency ablation (RFA) and cryotherapy. Our aim was to compare eradication rates of metaplasia and dysplasia with both these modalities.

Patients and methods: Retrospective review of prospectively collected database of patients who underwent endoscopic therapy for Barrett's dysplasia or IMC from 2006 to 2011 was performed. Demographic features, comorbidities, and endoscopic data including length of Barrett's segment, hiatal hernia size, interventions during the endoscopy and histological results were reviewed.

Results: Among 154 patients included, 73 patients were in the RFA and 81 patients were in the cryotherapy group. There was complete eradication of intestinal metaplasia (CE-IM) in 81 (52.6%), complete eradication of dysplasia (CE-D) in 133 (86.4%), and persistent dysplasia or cancer in 19 patients (12.3%). Compared to RFA, cryotherapy patients were found to be older and less likely to have undergone endoscopic mucosal resection. On multivariate analysis, patients who underwent RFA had a threefold higher odds of having CE-IM than those who underwent cryotherapy (odds ratio [OR] 2.9, 95% confidence interval [CI] 1.4-6.0, p = 0.004), but CE-D were similar between the two groups (OR 1.7, 95% CI 0.66-4.3, p = 0.28).

Conclusions: Endoscopic therapy is highly effective in eradication of Barrett's associated neoplasia. Patients who underwent cryotherapy were equally likely to achieve CE-D but not CE-IM than patients who underwent RFA. Patient characteristics and preferences may effect choice of treatment selection and outcomes.

Keywords: Ablation; Barrett’s esophagus; Cryotherapy; Dysplasia; Endoscopy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest All the authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Eradication rates of RFA and cryotherapy
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Arora Z, Garber A, Thota PN. Risk factors for Barrett’s esophagus. J Dig Dis. 2016;17:215–221. - PubMed
    1. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000;47:251–255. - PMC - PubMed
    1. Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol. 2015;111:30–50. - PMC - PubMed
    1. Haidry R, Lovat L, Sharma P. Radiofrequency ablation for Barrett’s dysplasia: past, present and the future? Curr Gastroenterol Rep. 2015;17:13. - PubMed
    1. Haidry R, Lovat L. Long-term durability of radiofrequency ablation for Barrett’s-related neoplasia. Curr Opin Gastroenterol. 2015;31:316–320. - PubMed

MeSH terms

LinkOut - more resources